Clinical Trial

Remifentanil vs. Nicardipine for Controlled Hypotension in Elective Nasal Surgery

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated June 22, 2026 (before its estimated July 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
This study compares remifentanil infusion versus nicardipine infusion for controlled hypotension during elective nasal surgery. Both agents are standard clinical methods. The study evaluates hemodynamic stability, surgical field quality (Fromme-Boezaart score), tissue perfusion, intraoperative blood loss, surgeon satisfaction, and perioperative adverse effects.
Trial Details
NCT Number NCT07660562
Lead Sponsor Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital
Conditions Nasal Surgery, Anesthesia, Controlled Hypotension for Nasal Surgeries
Enrollment 44 participants
Start Date 2026-06-25
Primary Completion 2026-07-01 (estimated)
Study Completion 2026-07-15 (estimated)
Updated on ClinicalTrials.gov 2026-06-22